Fresh Tracks Therapeutics, Inc. (FRTX)
OTCMKTS
· Delayed Price · Currency is USD
0.750
+0.010 (1.35%)
Dec 26, 2024, 4:00 PM EST
Fresh Tracks Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | -5.69 | -5.69 | -21.1 | -39.47 | -20.91 | -23.88 | Upgrade
|
| Depreciation & Amortization | 0.04 | 0.04 | 0.03 | 0.02 | 0.01 | 0.03 | Upgrade
|
| Other Amortization | - | - | - | - | - | 1.58 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.44 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | 0.03 | -0.04 | Upgrade
|
| Stock-Based Compensation | 1.92 | 1.92 | 2.16 | 2.33 | 1.99 | 1.53 | Upgrade
|
| Other Operating Activities | 0.06 | 0.06 | 0.06 | 1.55 | 0.5 | -2.01 | Upgrade
|
| Change in Accounts Payable | -0.17 | -0.17 | -1.03 | 1.02 | -1.68 | -1.82 | Upgrade
|
| Change in Unearned Revenue | - | - | - | - | -1.8 | -7.92 | Upgrade
|
| Change in Other Net Operating Assets | -0.5 | -0.5 | 0.56 | -1.59 | 1.82 | -3.89 | Upgrade
|
| Operating Cash Flow | -4.34 | -4.34 | -19.34 | -36.15 | -20.03 | -35.98 | Upgrade
|
| Capital Expenditures | - | - | -0.05 | -0.04 | -0.02 | -0.01 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | 13.02 | Upgrade
|
| Investment in Securities | - | - | - | - | 4.5 | 19.5 | Upgrade
|
| Investing Cash Flow | - | - | -0.05 | -0.04 | 4.48 | 32.51 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 7.4 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 0.44 | - | Upgrade
|
| Total Debt Issued | - | - | - | - | 0.44 | 7.4 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | - | -4.81 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | 0.44 | 2.59 | Upgrade
|
| Issuance of Common Stock | 6.57 | 6.57 | 1.23 | 33 | 38 | 0.05 | Upgrade
|
| Repurchase of Common Stock | -0.04 | -0.04 | -0.06 | -0.05 | - | - | Upgrade
|
| Financing Cash Flow | 6.53 | 6.53 | 1.18 | 32.95 | 38.44 | 2.64 | Upgrade
|
| Net Cash Flow | 2.19 | 2.19 | -18.2 | -3.23 | 22.88 | -0.84 | Upgrade
|
| Free Cash Flow | -4.34 | -4.34 | -19.38 | -36.18 | -20.06 | -35.99 | Upgrade
|
| Free Cash Flow Margin | -54.25% | -54.25% | -279.16% | -8956.44% | -1100.82% | -454.57% | Upgrade
|
| Free Cash Flow Per Share | -0.81 | -0.81 | -6.90 | -20.27 | -36.82 | -535.71 | Upgrade
|
| Cash Interest Paid | - | - | - | - | - | 0.43 | Upgrade
|
| Levered Free Cash Flow | -2.67 | -2.67 | -11.73 | -23.43 | -12.74 | -24.27 | Upgrade
|
| Unlevered Free Cash Flow | -2.67 | -2.67 | -11.72 | -23.39 | -12.74 | -24.54 | Upgrade
|
| Change in Net Working Capital | 0.65 | 0.65 | 0.4 | 0.55 | 1.61 | 11.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.